Congress Needs to F...
Health Care: Drugs
Sequenom Inc. (SQNM: NASDAQ)
$4.73 -0.17 | -3.47%
02/09/12 - 04:00 PM ET
2.32M / 2.54M
Vol / Avg. Vol:4.95 / 4.90
Open / Prev. Close:4.72 - 4.98
Today's Range:3.57 - 8.71
52 Wk Range:10.11%
Performance YTD:TheStreet Rating:
Portfolios with SQNM
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- Contributor10 Most Shorted Stocks in B...
- Contributor11 Biotech Stocks Loved or ...
- ContributorEarnings Short Squeeze Play...
- Usermulligans13
- Usermitetwo Portfolio 1
- Useregnaty Portfolio 1
- UserHUNGERLIFE
- UserSUPRATRADE Top Day Trader A...
- ContributorBarron's Research Reports 3...
Latest SQNM Headlines from TheStreet
- Sequenom CEO Presents At 30th Annual J.P. Morgan Healthcare Conference (Transcript) 01.25.12 | 05:01 am
- Sequenom Stock Falls On Unusually High Volume (SQNM) 01.20.12 | 02:01 pm
- Sequenom Stock Hits New 52-Week Low (SQNM) 12.07.11 | 02:12 pm
- Sequenom's CEO Presents At Lazard Capital Markets 8th Annual Healthcare Conference - Conference Call Transcript 11.30.11 | 02:11 pm
- 5 Stocks With Big Insider Buying 11.23.11 | 12:11 pm
- Sequenom Stock Hits New 52-Week Low (SQNM) 11.21.11 | 02:11 pm
- Sequenom CEO Hosts 2011 Analyst And Investor Day 11.15.11 | 07:11 pm
- Sequenom Stock Hits New 52-Week Low (SQNM) 11.10.11 | 02:11 pm
- Sequenom CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.04.11 | 07:11 pm
- Sequenom Stock Hits New 52-Week Low (SQNM) 11.02.11 | 01:11 pm
Press Releases for SQNM
- Sequenom CMM's MaterniT21⢠PLUS Test Expands Current Prenatal Testing Offering - PR Newswire 02.08.12 | 07:02 am
- Study Published In Genetics In Medicine Demonstrates Sequenom CMM MaterniT21 Test Accurately Detects Two Additional Fetal Trisomies - PR Newswire 02.02.12 | 04:02 pm
- Sequenom Announces Exercise In Full Of Over-Allotment Option And Completion Of Public Offering Of Common Stock - PR Newswire 01.25.12 | 04:01 pm
- Sequenom Announces 2011 Operational Highlights And Early 2012 Outlook - PR Newswire 01.08.12 | 08:01 pm
- Sequenom Announces Participation At The 30th Annual J.P. Morgan Healthcare Conference - PR Newswire 01.05.12 | 07:01 am
- Leading U.S. Healthcare Providers Ordering Sequenom Center For Molecular Medicine's MaterniT21 LDT - PR Newswire 12.19.11 | 07:12 am
- Sequenom Named To NASDAQ Global Select Market - PR Newswire 12.15.11 | 04:12 pm
- Sequenom Announces Participation At The 22nd Annual Oppenheimer And Company Healthcare Conference - PR Newswire 12.05.11 | 07:12 am
- Sequenom Announces Participation At The 23rd Annual Piper Jaffray Healthcare Conference - PR Newswire 11.22.11 | 07:11 am
- Sequenom To Host Analyst Day On Monday, November 14, 2011 - PR Newswire 11.14.11 | 07:11 am
Partner Headlines for SQNM
- Luminex Beats on Assay Boost - Analyst Blog - Zacks 02.07.12 | 09:02 am
- Trading Idea: These 5 Stocks Are Ready To Squeeze Higher - Benzinga 12.29.11 | 01:12 pm
- 7 Stocks Trading Below $6 With Heavy Insider Buying - Seeking Alpha 12.08.11 | 09:12 am
- Piper Jaffray Neutral on Sequenom; $6.25 PT - Benzinga 11.29.11 | 01:11 pm
- Buy And Sell Ideas Based On Tuesday's Big News Movers - Seeking Alpha 10.19.11 | 09:10 am
- 5 Stocks Surging Even As The Market Drops - Seeking Alpha 10.18.11 | 08:10 am
- 4 Healthcare Stocks With Smart Money And Insider Buying - Seeking Alpha 09.09.11 | 06:09 pm
- 6 'Buy' Rated Tech Stocks to Consider - Seeking Alpha 08.22.11 | 08:08 am
- Illumina Teams with Sequenom - Analyst Blog - Zacks 07.12.11 | 06:07 pm
- Luminex Gets EraGen for $34M - Analyst Blog - Zacks 06.22.11 | 07:06 pm
